Addressing Neurodevelopment, Qualify of Life and Emerging Therapies in Dravet Syndrome Patients cover art

Addressing Neurodevelopment, Qualify of Life and Emerging Therapies in Dravet Syndrome Patients

Addressing Neurodevelopment, Qualify of Life and Emerging Therapies in Dravet Syndrome Patients

By: Annenberg Center for Health Sciences
Listen for free

About this listen

 The combined developmental and epileptic encephalopathy of Dravet syndrome provides significant diagnostic and treatment challenges. This activity focuses on key characteristics and clinical presentations of Dravet syndrome with the aim of early identification of persons with the syndrome, timely initiation and appropriate use of approved medications, and the need for a multidisciplinary care plan, particularly as individuals transition into adulthood. Dr. Wirrell also provides an overview of investigational disease-modifying therapies.Annenberg Center for Health Sciences Hygiene & Healthy Living Physical Illness & Disease
Episodes
  • Disease-Modifying Therapies

    Disease-Modifying Therapies
    Apr 29 2026
    • Antisense oligonucleotide– zorevunersen
    • Histamine antagonist– clemizole hydrochloride
    • Serotonin agonist– bexicaserin
    • Gene therapy– ETX101
    Show More Show Less
    13 mins
  • Optimizing Standards of Care

    Optimizing Standards of Care
    Apr 29 2026
    • Seizure management–cannabidiol, fenfluramine, stiripentol; ketogenic diet
    • Multidisciplinary care
    • Dravet Syndrome Foundation Transition Guide
    • Seizure action plan
    Show More Show Less
    20 mins
  • Improving Diagnosis

    Improving Diagnosis
    Apr 29 2026
    • Key features and triggers
    • Imaging
    • DS mimics
    • Genetic testing
    Show More Show Less
    8 mins
No reviews yet